1. Home
  2. BMHL vs COYA Comparison

BMHL vs COYA Comparison

Compare BMHL & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluemount Holdings Limited Class B Ordinary Shares

BMHL

Bluemount Holdings Limited Class B Ordinary Shares

HOLD

Current Price

$5.74

Market Cap

155.4M

Sector

N/A

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$4.55

Market Cap

124.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMHL
COYA
Founded
2016
2020
Country
Hong Kong
United States
Employees
9
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.4M
124.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BMHL
COYA
Price
$5.74
$4.55
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.80
AVG Volume (30 Days)
3.5K
262.1K
Earning Date
06-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,945,753.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$763.10
P/E Ratio
$66.66
N/A
Revenue Growth
N/A
123.57
52 Week Low
$2.72
$3.71
52 Week High
$6.35
$7.75

Technical Indicators

Market Signals
Indicator
BMHL
COYA
Relative Strength Index (RSI) 51.69 37.83
Support Level $5.58 $4.45
Resistance Level $6.35 $5.18
Average True Range (ATR) 0.30 0.38
MACD -0.11 -0.14
Stochastic Oscillator 34.55 7.56

Price Performance

Historical Comparison
BMHL
COYA

About BMHL Bluemount Holdings Limited Class B Ordinary Shares

Bluemount Holdings Ltd through its operating subsidiaries, is a Hong Kong-based consulting and advisory, financial services, and luxury timepiece trading provider. The Company provides consulting and advisory services on business development strategies, including seeking suitable transaction projects for business development or diversification and suitable business partners or investors for fund-raising projects. Its services are centered around three core offerings: Business Transformation, Strategy, and Transactions. The Company also sources, buys, and sells brand-new luxury branded timepieces. It operates through two reportable segments: security-related services and asset management, and trading of timepieces, with the trading of timepieces generating maximum revenue.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: